Vistagen Therapeutics (VTGN) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.54
-0.5
-0.47
-0.43

Details

Expected EPS
-0.47674
Actual EPS
-0.54
Surprise EPS
-0.06
Surprise Percent
+13.27%

Description

Vistagen Therapeutics (VTGN) has reported earnings of -0.54 per share for Q4 2025.

0 Comments

Share your thoughts